is semaglutide hard on your kidneys Recent medical milestones include the 2025 FDA approval of Ozempic (semaglutide) specifically to slow the progression of chronic kidney disease (CKD) in patients with type 2 diabetes. Clinical trials Ozempic May Help Treat Kidney

Survodutide (BI 456906) is a novel subcutaneous GCGR/GLP-1R dual agonist in development for the treatment of people with type 2 diabetes, obesity and non-alcoholic steatohepatitis (NASH)

In the STEP-1 clinical trial published in the New England Journal of Medicine , participants lost an average of 15% of their body weight over 68 weeks

Because GLP-1 medications can slow digestion and affect appetite, choosing compact, familiar options within high-protein snacks often feels more comfortable and predictable in the body

If you feel the need to wash a bite down, its okay to take a small sip, she says, but generally focus on hydrating more outside of mealtimes

This shortfall adds to the timeline